FDA is removing the ‘black box’ warning on hormone treatments for women in menopause. Here’s what you need to know
FDA removed the black-box warning last year, leading to rising demand for safer transdermal estrogen patches amid ongoing pharmacy shortages nationwide.
6 Articles
6 Articles
Why the 'mad scramble' to fill hormone therapy prescriptions for menopause
With the removal of the black-box warning on hormone therapy for menopause, some providers and patients report shortages or delays, waiting for a pharmacy to restock transdermal estrogen patches.When Jennifer Skoog Mondesir headed to the pharmacy to pick up her estrogen patch, she never knew what she’d find.Mondesir, who is in her late 40s and in perimenopause, relies on the patch to help improve symptoms, including low energy. She lives in Jers…
FDA is removing the ‘black box’ warning on hormone treatments for women in menopause. Here’s what you need to know
For years, Cathleen “Cat” Brown, a Philadelphia obstetrician and gynecologist, would listen to patients complaining of hot flashes, brain fog and painful sex, and prescribe estrogen as a safe option for easing their menopausal symptoms.
Why the 'mad scramble' to fill hormone therapy prescriptions for menopause - TPR: The Public's Radio
With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches. The post Why the ‘mad scramble’ to fill hormone therapy prescriptions for menopause appeared first on TPR: The Public's Radio.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





